Literature DB >> 4370080

Hypnotic effects of L-tryptophan.

E Hartmann, J Cravens, S List.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4370080     DOI: 10.1001/archpsyc.1974.01760150098014

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


× No keyword cloud information.
  17 in total

1.  Preliminary randomized double-blind placebo-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects.

Authors:  R D Levitan; J H Shen; R Jindal; H S Driver; S H Kennedy; C M Shapiro
Journal:  J Psychiatry Neurosci       Date:  2000-09       Impact factor: 6.186

2.  Evaluation of L-tryptophan for treatment of insomnia: a review.

Authors:  D Schneider-Helmert; C L Spinweber
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  L-Tryptophan: Biochemical, nutritional and pharmacological aspects.

Authors:  E L Sainio; K Pulkki; S N Young
Journal:  Amino Acids       Date:  1996-03       Impact factor: 3.520

4.  Cerebral transmitter precursors and metabolites in advanced renal disease.

Authors:  P A Sullivan; D Murnaghan; N Callaghan; B D Kantamaneni; G Curzon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-07       Impact factor: 10.154

5.  L-tryptophan administered to chronic sleep-onset insomniacs: late-appearing reduction of sleep latency.

Authors:  C L Spinweber
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

6.  Effects of L-tryptophan and ethanol on sleep parameters in the rat.

Authors:  S Y Hill; R B Reyes
Journal:  Psychopharmacology (Berl)       Date:  1978-07-19       Impact factor: 4.530

7.  Similar effect on REM sleep but differential effect on slow wave sleep of the two 5-HT uptake inhibitors zimeldine and alaproclate in cats and rats.

Authors:  L Sommerfelt; E R Hauge; R Ursin
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

8.  Alterations of cerebrospinal fluid 5-hydroxyindoleacetic acid, and total blood serotonin content during clozapine treatment.

Authors:  C M Banki
Journal:  Psychopharmacology (Berl)       Date:  1978-03-01       Impact factor: 4.530

9.  Experimental studies on 3,4-methylenedioxymethamphetamine (MDA, "ecstasy") and its potential to damage brain serotonin neurons.

Authors:  G A Ricaurte; U D McCann
Journal:  Neurotox Res       Date:  2001-01       Impact factor: 3.911

10.  Chronic insomnia: effects of tryptophan, flurazepam, secobarbital, and placebo.

Authors:  E Hartmann; J G Lindsley; C Spinweber
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.